Literature DB >> 23820637

Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.

Charles A Schiffer1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23820637     DOI： 10.1038/nrclinonc.2013.113

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  C A Schiffer; K C Anderson; C L Bennett; S Bernstein; L S Elting; M Goldsmith; M Goldstein; H Hume; J J McCullough; R E McIntyre; B L Powell; J M Rainey; S D Rowley; P Rebulla; M B Troner; A H Wagnon
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

2.  The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.

Authors:  L A GAYDOS; E J FREIREICH; N MANTEL
Journal:  N Engl J Med       Date:  1962-05-03       Impact factor: 91.245

3.  What to do if there is no evidence? The issue of surgical procedures in patients with thrombocytopenia.

Authors:  Charles A Schiffer
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

4.  Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.

Authors:  H Wandt; M Frank; G Ehninger; C Schneider; N Brack; A Daoud; I Fackler-Schwalbe; J Fischer; R Gäckle; T Geer; P Harms; B Löffler; S Ohl; B Otremba; M Raab; P Schönrock-Nabulsi; G Strobel; R Winter; H Link
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

5.  Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.

Authors:  Hannes Wandt; Kerstin Schaefer-Eckart; Knut Wendelin; Bettina Pilz; Martin Wilhelm; Markus Thalheimer; Ulrich Mahlknecht; Anthony Ho; Markus Schaich; Michael Kramer; Martin Kaufmann; Lothar Leimer; Rainer Schwerdtfeger; Roland Conradi; Gottfried Dölken; Anne Klenner; Mathias Hänel; Regina Herbst; Christian Junghanss; Gerhard Ehninger
Journal:  Lancet       Date:  2012-08-08       Impact factor: 79.321

6.  Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.

Authors:  K D Heckman; G J Weiner; C S Davis; R G Strauss; M P Jones; C P Burns
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

7.  The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

Authors:  P Rebulla; G Finazzi; F Marangoni; G Avvisati; L Gugliotta; G Tognoni; T Barbui; F Mandelli; G Sirchia
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

8.  Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.

Authors: 
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

9.  A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.

Authors:  H Wandt; K Schaefer-Eckart; M Frank; J Birkmann; M Wilhelm
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

10.  A no-prophylaxis platelet-transfusion strategy for hematologic cancers.

Authors:  Simon J Stanworth; Lise J Estcourt; Gillian Powter; Brennan C Kahan; Claire Dyer; Louise Choo; Lekha Bakrania; Charlotte Llewelyn; Timothy Littlewood; Richard Soutar; Derek Norfolk; Adrian Copplestone; Neil Smith; Paul Kerr; Gail Jones; Kavita Raj; David A Westerman; Jeffrey Szer; Nicholas Jackson; Peter G Bardy; Dianne Plews; Simon Lyons; Linley Bielby; Erica M Wood; Michael F Murphy
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245
  10 in total
  4 in total

1.  In Reply.

Authors:  Hannes Wandt; Kerstin Schäfer-Eckart; Andreas Greinacher
Journal:  Dtsch Arztebl Int       Date:  2015-07-20       Impact factor: 5.594

2.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Marialena Trivella; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

Review 3.  Platelet transfusion in hematology, oncology and surgery.

Authors:  Hannes Wandt; Kerstin Schäfer-Eckart; Andreas Greinacher
Journal:  Dtsch Arztebl Int       Date:  2014-11-28       Impact factor: 5.594

Review 4.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Reem Malouf; Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.